SCHEMBL4471542

SCHEMBL4471542

Cc1cc([N+](=O)[O-])ccc1N1CCCNC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
TDP1 Q9NUW8 3/20 0.46
CYP3A4 P08684 3/20 0.46
TSHR P16473 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CASP6 P55212 2/20 0.43
POLB P06746 1/20 0.43
APEX1 P27695 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
GAA P10253 1/20 0.43
NPC1 O15118 1/20 0.41
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPK1 P28482 1/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3642120 0.84 ALDH1A1 (0.41) ALDH1A1TDP1CYP3A4L3MBTL1CASP6
SCHEMBL3641871 0.84 POLB (0.43) ALDH1A1TDP1CYP3A4CASP6POLB
SCHEMBL3643439 0.83 ALDH1A1 (0.50) ALDH1A1TDP1CYP3A4L3MBTL1CASP6
SCHEMBL24105032 0.81 TDP1 (0.55) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL17979962 0.81 TSHR (0.47) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL30168136 0.81 TDP1 (0.55) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL8306531 0.80 ALDH1A1 (0.51) ALDH1A1NPC1SMN1; SMN2NPSR1RAB9A
SCHEMBL85584 0.80 TDP1 (0.53) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL4473728 0.79 MAPT (0.53) ALDH1A1POLBGAALMNASMN1; SMN2
SCHEMBL5415229 0.78 TDP1 (0.52) ALDH1A1TDP1CYP3A4TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476663-B2 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-13 US disclosed
EP-1747217-A1 NOVEL SUBSTITUTED THIOPHENECARBOXAMIDES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2007-01-31 EP disclosed
US-20050277628-A1 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-12-15 US disclosed
WO-2005111029-A1 NOVEL SUBSTITUTED THIOPHENECARBOXAMIDES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277628-A1 Substituted thiophene carboxamides OTC, SLC22A8, DDC ALDH1A1 910/4885TDP1 390/4885CYP3A4 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.